102 results
8-K
EX-99.1
ORTX
Orchard Therapeutics plc
14 Sep 21
Orchard Therapeutics Bolsters R&D and Technical Operations Leadership with New Executive Appointments
7:00am
of increasing responsibility since 2004, most recently serving as global head of cell and gene therapies. In this role, Dr. Loggia led multidisciplinary … responsibility,
most recently serving as senior vice president of global medical affairs, diagnostics, clinical operations and data management.
She
6-K
EX-99.3
ORTX
Orchard Therapeutics plc
3 Jun 19
Current report (foreign)
7:00am
responsibility with respect to the accuracy of such information. Citibank, N.A. does not, and should not be deemed to, express any opinion with respect
6-K
EX-99.1
ORTX
Orchard Therapeutics plc
7 Dec 18
Orchard Therapeutics Appoints Industry Veteran Alicia Secor to its Board of Directors
7:45am
BioPharma Corp, and roles of increasing responsibility at Genzyme, including serving as vice president and general manager of the metabolic disease
6-K
EX-99.1
ORTX
Orchard Therapeutics plc
19 Mar 19
Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer
9:39am
responsibility in operations. Most recently, she served as vice president of development supply chain, overseeing end-to-end supply chain, development labs
20-F/A
EX-4.12
f92vcg 9hk52bq6v6
26 Apr 19
Annual report (foreign) (amended)
4:54pm
20-F
EX-4.12
faf4xsj80
22 Mar 19
Annual report (foreign)
8:02am
6-K
EX-99.1
eqarn075f3bzh77p
21 Mar 19
Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights
7:04am
8-K
EX-2.2
c70o7zc
24 Jan 24
Termination of a Material Definitive Agreement
4:17pm
F-1
EX-10.4
zuclpcg7z3fwo9
4 Oct 18
Registration statement (foreign)
4:48pm
6-K
EX-99.1
ejxhhfu27
3 Jun 19
Current report (foreign)
7:00am
F-1/A
EX-2.1
xmrpqupidt4izz9
23 Oct 18
Registration statement (foreign) (amended)
6:15am
DRS
EX-2.1
ys9g8kci5 w3ixduwny4
6 Aug 18
Draft registration statement
12:00am
F-1/A
EX-5.1
0k4tt b2qd
26 Oct 18
Registration statement (foreign) (amended)
10:08am
DRS
EX-10.4
bexjf
6 Aug 18
Draft registration statement
12:00am
F-1
EX-5.1
54kxz4p19 hvmncyb9p
3 Jun 19
Registration statement (foreign)
4:33pm
S-8
EX-5.1
0idzcp
30 Oct 18
Registration of securities for employees
9:48pm
POSASR
EX-5.3
2j8rg2ctfwt7qz
28 Feb 20
Automatic shelf registration (post-effective amendment)
12:00am
F-1
EX-2.1
juq a19p4kgk4h9qpgws
4 Oct 18
Registration statement (foreign)
4:48pm
F-1/A
EX-5.1
wsvzef
23 Oct 18
Registration statement (foreign) (amended)
6:15am